Condition: Chronic Lymphocytic Leukemia (CLL) · Sponsor: AbbVie
An observational study to assess the effectiveness, health economic-relevant costs and participant reported outcomes in participants with Chronic lymphocytic leukemia (CLL) receiving venetoclax as a monotherapy or in combination with rituximab, obinutuzumab, ibrutinib, or acalabrutinib as prescribed at the discretion of the physician and in accordance with local clinical practice and label.
This description comes directly from the study's public registry record.
Johannes Huelsenbeck · +49 611-1720-3036 · johannes.huelsenbeck@abbvie.com
Stefan Lorenz · stefan.lorenz@abbvie.com
Always discuss trial participation with your own doctor first.
| Universitaetsklinikum St. Poelten /ID# 221152 | Sankt Pölten, Lower Austria, Austria | Completed |
| Medizinische Universitaet Graz /ID# 221155 | Graz, Styria, Austria | Completed |
| Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 221153 | Salzburg, Austria | Active Not Recruiting |
| Hanusch Krankenhaus /ID# 221151 | Vienna, Austria | Completed |
| Stauferklinikum Schwaebisch Gmuend /ID# 201518 | Mutlangen, Baden-Wurttemberg, Germany | Completed |
| Onkologische Praxis /ID# 201545 | Stuttgart, Baden-Wurttemberg, Germany | Completed |
| Schwarzwald-Baar-Klinikum /ID# 208176 | Villingen-Schwenningen, Baden-Wurttemberg, Germany | Active Not Recruiting |
| MVZ am Klinikum Aschaffenburg Onkologie /ID# 201548 | Aschaffenburg, Bavaria, Germany | Active Not Recruiting |
| Studienzentrum Aschaffenburg /ID# 204125 | Aschaffenburg, Bavaria, Germany | Active Not Recruiting |
| Gemeinschaftspraxis Dr. Heinrich und Prof. Bangerter /ID# 200950 | Augsburg, Bavaria, Germany | Completed |
| Drs. Tanzer, Chirca, Stoeberl /ID# 202613 | Bad Reichenhall, Bavaria, Germany | Completed |
| Internistische Schwerpunktpraxen, Erlangen /ID# 200949 | Erlangen, Bavaria, Germany | Completed |
+ 58 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03342144